Obesity in Sweden

From WikiMD's WELLNESSPEDIA


Sweden, a country located in Europe, had an adult obesity rate of 20.6% in 2016, ranking it 96th globally. This rate is a significant health concern, as obesity is linked to a variety of serious health conditions, including heart disease, diabetes, and certain types of cancer.

Healthcare in Sweden[edit]

Sweden's healthcare system is primarily funded by taxes levied by county councils and municipalities. The system is decentralized, with responsibility for providing healthcare services largely falling to the 21 county councils and 290 municipalities.

Obesity in Sweden[edit]

In 2016, the adult obesity rate in Sweden was 20.6%, placing it 96th in the world. This rate has been steadily increasing over the past few decades, mirroring a global trend in rising obesity rates.

Weight Loss Facilities in Sweden[edit]

There are several well-known healthcare facilities in Sweden that specialize in weight loss and obesity treatment. These include:

  • LIVI: A digital healthcare provider that offers virtual consultations with doctors and psychologists, including advice and treatment for weight loss.
  • Itrim: A Swedish company that offers personalized weight loss programs, including dietary advice, exercise plans, and behavioral change support.
  • Capio St. Göran's Hospital: This hospital in Stockholm has a specialized obesity center that offers surgical and non-surgical weight loss treatments.

See Also[edit]

References[edit]


the World
Countries
Afghanistan / Albania / Algeria / Andorra / Angola / Antigua and Barbuda / Argentina / Armenia / Australia / Austria / Azerbaijan / Bahamas / Bahrain / Bangladesh / Barbados / Belarus / Belgium / Belize / Benin / Bhutan / Bolivia / Bosnia and Herzegovina / Botswana / Brazil / Brunei / Bulgaria / Burkina Faso / Burundi / Cambodia / Cameroon / Canada / Cape Verde / Central African Republic / Chad / Chile / China / Colombia / Comoros / Costa Rica / Croatia / Cuba / Cyprus / Czech Republic / Democratic Republic of the Congo / Denmark / Djibouti / Dominica / Dominican Republic / Ecuador / Egypt / El Salvador / Equatorial Guinea / Eritrea / Estonia / Eswatini / Ethiopia / Federated States of Micronesia / Fiji / Finland / France / Gabon / Gambia / Georgia / Germany / Ghana / Greece / Grenada / Guatemala / Guinea / Guinea-Bissau / Guyana / Haiti / Honduras / Hungary / Iceland / India / Indonesia / Iran / Iraq / Ireland / Israel / Italy / Ivory Coast / Jamaica / Japan / Jordan / Kazakhstan / Kenya / Kiribati / Kosovo / Kuwait / Kyrgyzstan / Laos / Latvia / Lebanon / Lesotho / Liberia / Libya / Liechtenstein / Lithuania / Luxembourg / Madagascar / Malawi / Malaysia / Maldives / Mali / Malta / Marshall Islands / Mauritania / Mauritius / Mexico / Moldova / Monaco / Mongolia / Montenegro / Morocco / Mozambique / Myanmar / Namibia / Nauru / Nepal / Netherlands / New Zealand / Nicaragua / Niger / Nigeria / North Korea / North Macedonia / Norway / Oman / Pakistan / Palau / Palestine / Panama / Papua New Guinea / Paraguay / Peru / Philippines / Poland / Portugal / Qatar / Republic of the Congo / Romania / Russia / Rwanda / Saint Kitts and Nevis / Saint Lucia / Saint Vincent and the Grenadines / Samoa / San Marino / Saudi Arabia / Senegal / Serbia / Seychelles / Sierra Leone / Singapore / Slovakia / Slovenia / Solomon Islands / Somalia / South Africa / South Korea / South Sudan / Spain / Sri Lanka / Sudan / Suriname / Sweden / Switzerland / Syria / São Tomé and Príncipe / Taiwan / Tajikistan / Tanzania / Thailand / Timor-Leste / Togo / Tonga / Trinidad and Tobago / Tunisia / Turkey / Turkmenistan / Tuvalu / Uganda / Ukraine / United Arab Emirates / United Kingdom / United States / Uruguay / Uzbekistan / Vanuatu / Vatican City / Venezuela / Vietnam / Western Sahara / Yemen / Zambia / Zimbabwe

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Obesity_in_Sweden&oldid=5162990"